COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks.

Rashed NoorNishat TasnimChandrika Saha

Published in: Current clinical microbiology reports (2021)

Application of CP therapy has been conducted since long time; and for the mitigation of COVID-19 severity, such pharmaceutical strategy is also being employed in spite of several risks which actually can be monitored as well as optimized in order to combat the SARS-CoV-2 infection.

Keyphrases

coronavirus disease
sars cov
human health
climate change
respiratory syndrome coronavirus
stem cells